Novacta Biosystems Limited
Records under this name other than patents Novacta Biosystems Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Novacta Biosystems Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,234,006 | Compounds Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,198,054 | Method for the chemo-selective enzymatic hydrolysis if a diester compound for preparing a monoester monoacid compound Lapsed on the fee record Ended Jun 12, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2024 | From the USPTO record |
| US 9,192,569 | Formulations for infusion of type B lantibiotics Lapsed on the fee record Ended Nov 24, 2019 · From the USPTO record | Lapsed on the fee record | Ended Nov 24, 2019 | From the USPTO record |
| US RE45,003 | Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. liguriae Lapsed on the fee record Ended Aug 2, 2019 · From the USPTO record | Lapsed on the fee record | Ended Aug 2, 2019 | From the USPTO record |
| US 9,006,392 | Actagardine derivatives, and pharmaceutical use thereof Lapsed on the fee record Ended Apr 14, 2019 · From the USPTO record | Lapsed on the fee record | Ended Apr 14, 2019 | From the USPTO record |
| US 8,741,945 | Compounds Lapsed on the fee record Ended Jun 3, 2018 · From the USPTO record | Lapsed on the fee record | Ended Jun 3, 2018 | From the USPTO record |
| US 8,729,031 | Compounds Lapsed on the fee record Ended May 20, 2018 · From the USPTO record | Lapsed on the fee record | Ended May 20, 2018 | From the USPTO record |
| US 8,575,094 | Use of type-B lantibiotic-based compounds having antimicrobial activity Lapsed on the fee record Ended Nov 5, 2017 · From the USPTO record | Lapsed on the fee record | Ended Nov 5, 2017 | From the USPTO record |
| US 8,465,947 | Lantibiotic biosynthetic gene clusters from A. garbadinensis and A. liguriae Lapsed on the fee record Ended Jun 18, 2017 · From the USPTO record | Lapsed on the fee record | Ended Jun 18, 2017 | From the USPTO record |
| US 8,329,644 | Lantibiotic-based compounds having antimicrobial activity Lapsed on the fee record Ended Dec 11, 2016 · From the USPTO record | Lapsed on the fee record | Ended Dec 11, 2016 | From the USPTO record |